共 97 条
[1]
Lloyd-Jones DM(2004)Lifetime risk for development of atrial fibrillation: the Framingham Heart Study Circulation 110 1042-1046
[2]
Wang TJ(2020)ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) Eur Heart J 22 983-988
[3]
Leip EP(1991)Atrial fibrillation as an independent risk factor for stroke: the Framingham study Stroke 113 365-370
[4]
Hindricks G(2002)A population-based study of mortality among patients with atrial fibrillation or flutter Am J Med 27 1765-1769
[5]
Potpara T(1996)Acute stroke with atrial fibrillation. The Copenhagen Stroke Study Stroke 82 2n-9n
[6]
Dagres N(1998)Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates Am J Cardiol 33 2719-2747
[7]
Wolf PA(2012)2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association Eur Heart J. 131 492-501
[8]
Abbott RD(1999)Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis Ann Intern Med 34 170-176
[9]
Kannel WB(2013)The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy Eur Heart J 138 1093-1100
[10]
Vidaillet H(2010)A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey Chest 7 e017157-2388